Invention Grant
- Patent Title: Substituted imidazopyrazines as Akt kinase inhibitors
- Patent Title (中): 取代的咪唑并嗪作为Akt激酶抑制剂
-
Application No.: US14370831Application Date: 2013-01-08
-
Publication No.: US09260435B2Publication Date: 2016-02-16
- Inventor: Lars Bärfacker , William Scott , Andrea Hägebarth , Stuart Ince , Hartmut Rehwinkel , Oliver Politz , Roland Neuhaus , Ulf Bömer
- Applicant: Bayer Intellectual Property GmbH , BAYER PHARMA AKTIENGESELLSCHAFT
- Applicant Address: DE Monheim
- Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
- Current Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
- Current Assignee Address: DE Monheim
- Priority: EP12150558 20120110
- International Application: PCT/EP2013/050196 WO 20130108
- International Announcement: WO2013/104610 WO 20130718
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K45/06 ; A61K31/4985
Abstract:
Compounds of formula (I) which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.
Public/Granted literature
- US20150005309A1 SUBSTITUTED IMIDAZOPYRAZINES AS AKT KINASE INHIBITORS Public/Granted day:2015-01-01
Information query
